Agios Pharmaceuticals (LTS:0HB0) Inventories, Raw Materials & Components : $0.09 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Agios Pharmaceuticals Inventories, Raw Materials & Components?

Agios Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Mar. 2024 was $0.09 Mil.

Agios Pharmaceuticals's quarterly raw materials declined from Sep. 2023 ($0.47 Mil) to Dec. 2023 ($0.05 Mil) but then increased from Dec. 2023 ($0.05 Mil) to Mar. 2024 ($0.09 Mil).

Agios Pharmaceuticals's annual raw materials stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.05 Mil).

Agios Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Agios Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agios Pharmaceuticals Inventories, Raw Materials & Components Chart

Agios Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

0.18

0.05

Agios Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															-	0.47	0.47	0.05	0.09

Agios Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Agios Pharmaceuticals (LTS:0HB0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agios Pharmaceuticals Inc (LTS:0HB0) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

AGIO:USA AGIO:Mexico 8AP:Germany 8AP:Germany

Address

88 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.agios.com

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Agios Pharmaceuticals (LTS:0HB0) Headlines

No Headlines